AsymmetRx Ends Cancer Test IP Suit Against Dako

Law360, New York (July 1, 2010, 2:49 PM EDT) -- AsymmetRx Inc. and Harvard College have cut a deal with Danish drugmaker Dako Denmark A/S while in arbitration proceedings that resolves their infringement suit in district court over patents related to diagnostic test kits for prostate cancer.

Judge William G. Young of the U.S. District Court for the District of Massachusetts on Wednesday dismissed AsymmetRx and Harvard’s case against Dako with prejudice and ordered each party to take care of its own legal fees and costs.

The court closed the case in June 2009 to await...
To view the full article, register now.